Arbaclofen
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Arbaclofen or arbaclofen placarbil or ARBaclofen or Ontinua ER is an investigational drug related to baclofen, it is being investigated for muscle spasticity (muscle spasms).[1] Arbaclofen is a GABA-B agonist, and is being investigated as a muscle relexant for multiple sclerosis.[2]
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Costs and availability[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- [https://reference.medscape.com/drug/ontinua-er-arbaclofen-1000093 Ontinua ER (arbaclofen) - Medscape
References[edit | edit source]
- ↑ https://www.rxlist.com/consumer_arbaclofen/drugs-condition.htm
- ↑ "Ontinua ER (arbaclofen) dosing, indications, interactions, adverse effects, and more". Medscape. Retrieved January 16, 2022.
